SLC7A2 and hepatocellular carcinoma: Interestingly, an immunocompetent subcutaneous HCC mouse model in C57BL/6 was served as tumorigenesis and the results showed that SLC7A2 overexpression significantly suppressed tumor growth (Fig. 2F, G).